APA način citiranja

Vij, R., Wang, M., Kaufman, J. L., Lonial, S., Jakubowiak, A. J., Stewart, A. K., . . . Siegel, D. S. (2012). An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma. American Society of Hematology.

Čikaški stil citiranja

Vij, Ravi, et al. An Open-label, Single-arm, Phase 2 (PX-171-004) Study of Single-agent Carfilzomib in Bortezomib-naive Patients With Relapsed And/or Refractory Multiple Myeloma. American Society of Hematology, 2012.

MLA način citiranja

Vij, Ravi, et al. An Open-label, Single-arm, Phase 2 (PX-171-004) Study of Single-agent Carfilzomib in Bortezomib-naive Patients With Relapsed And/or Refractory Multiple Myeloma. American Society of Hematology, 2012.